Skip to main content
Philip Friedlander, MD, Oncology, New York, NY

PhilipAFriedlanderMD

Oncology New York, NY

Assistant Professor, Medicine, Icahn School of Medicine at Mount Sinai

Overview of Dr. Friedlander

Dr. Philip Friedlander is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including The Mount Sinai Hospital, Mount Sinai West, Mount Sinai Morningside, Mount Sinai Beth Israel, Mount Sinai Hospital of Queens, and Valley Hospital. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 18 years. Dr. Friedlander accepts several types of health insurance, listed below. He is one of 187 doctors at The Mount Sinai Hospital and one of 122 doctors at Mount Sinai Beth Israel who specialize in Oncology. He has more than 30 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2002 - 2005
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1999

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • NY State Medical License
    NY State Medical License 2000 - 2025
  • MA State Medical License
    MA State Medical License 2005 - 2012
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Experts Agree Sun Exposure Is a Cancer Risk
    Experts Agree Sun Exposure Is a Cancer RiskSeptember 7th, 2022
  • Immune-Boosting Components Double the Effectiveness of Melanoma Vaccine Candidate in Phase II Trial
    Immune-Boosting Components Double the Effectiveness of Melanoma Vaccine Candidate in Phase II TrialNovember 17th, 2020
  • 'Truly Amazing': Huge Change in Melanoma Prognosis
    'Truly Amazing': Huge Change in Melanoma PrognosisOctober 26th, 2019
  • Join now to see all

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    Anthem Blue Access PPO
    Anthem Blue Preferred HMO
    BCBS Blue Card PPO
    BCBS California PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    Health Net California Large Group PPO
    HealthAmerica HealthAssurance PPO
    Humana ChoiceCare Network PPO
    Medical Mutual of Ohio SuperMed Plus
    Medical Mutual of Ohio SuperMed POS
    Multiplan PHCS PPO
    Multiplan PHCS PPO - Kaiser
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment